The Complaint alleges that Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose the following adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants or recklessly disregarded by them. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants did not fully disclose the circumstances under which the Heart-1 trial would be halted; (2) Defendants overstated the potential benefits of its proprietary LNP delivery system (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.